placebo (two doses)

BIOLOGICAL2 trials

Sponsors

Jiangsu Province Centers for Disease Control and Prevention, J L Marsh

Conditions

Ebola Virus DiseaseOsteoarthritisPost-traumatic Osteoarthritis

Phase 1

A Phase I Clinical Trial to Evaluate the Ebola Adenovirus Vector Vaccine (Ad5-EBOV) in Healthy Adults.

CompletedNCT02326194

Jiangsu Province Centers for Disease Control and PreventionEbola Virus Disease

Start: 2014-12-31End: 2015-07-31Updated: 2015-08-28

Translating Metabolic Responses to Mechanical Insult Into Early Interventions to Prevent PTOA

TerminatedNCT04589611

J L MarshOsteoarthritis, Post-traumatic Osteoarthritis

Start: 2022-07-20End: 2025-05-01Updated: 2026-07-06

Related Papers

Immunity duration of a recombinant adenovirus type-5 vector-based Ebola vaccine and a homologous prime-boost immunisation in healthy adults in China: final report of a randomised, double-blind, placebo-controlled, phase 1 trial.

2016-12-2376 citations

Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial.

2015-03-25127 citations